Effects of the adjunctive probiotic <scp>VSL</scp>#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial

Nitin Gupta, Ashish Kumar, Praveen Sharma, Vishal Garg, Barjesh Chander Sharma, Shiv Kumar Sarin

Liver International · 2013 · 76 citations · 16 references

Abstract

Adjunctive probiotic (VSL#3) improved the response rate to propranolol therapy and was safe and well tolerated in patients with cirrhosis. Adjunctive probiotic therapy merits further study for reduction in portal pressure.

References

16